Cigarette smoking remains the largest preventable cause of premature death in developed
countries. Until recently nicotine replacement therapy (NRT) has been the only recognised …

Nicotine addiction is a chronic relapsing condition that can be difficult to treat. Until recently,
pharmacological options for the treatment of tobacco dependence were primarily limited to …

The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major
change in the options available for smoking cessation pharmacotherapy. Bupropion is a …

Objectives: To identify predictors of smoking abstinence at the end of medication use that
could assist in the optimal use of a sustained-release (SR) form of bupropion for treating …

Bupropion SR was introduced for smoking cessation in the US in 1997. This review
assesses the efficacy and safety of bupropion SR for treatment of tobacco dependence …

Research on smoking has increased in the past several years, andmany new therapeutic
modalities have been developed. Primaryintervention for smoking cessation begins with …

Sustained release bupropion (amfebutamone) is a non-nicotine agent that is indicated as an
aid to smoking cessation. In 2 large well designed clinical trials, sustained release …

Tønnesen P, Tonstad S, Hjalmarson A, Lebargy F, van Spiegel PI, Hider A, Sweet R,
Townsend J (Gentofte University Hospital, Gentofte, Denmark; Clinic for Preventive …

Tobacco use, particularly cigarette smoking, is now a global pandemic. The expected
morbidity and mortality from smoking-attributable diseases will continue to rise for the next …

Background Many persons who attempt to quit smoking have made previous unsuccessful
attempts to quit with pharmacologic aids. An understanding of the impact of these previous …